As stated yesterday in my post it reinforces the high risk shorters are in. "Are we confident there will be no announcement this week?" well the answer is a definite No. Mesoblast actions are structured and prepared very well we are on track and should be proud of this innovative Australian company doing their best to improve the quality of human life.
At these prices it showcases the high risk vs reward the short brokers for the brokerage firms are taking with little fat on the bone. Hinging past CR's and current adverse conditions within the ASX provides no assurance for optimal success. Meso Nasdaq and MSB ASX demonstrates how well they maintain confidentiality and as will the FDA. Are we confident there will be no announcement this week?
Cell Therapy News/Articles, page-15604
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $5.699M | 3.943M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 122380 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 11015 | 2 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |